Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

NCT01659138 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

28

Enrollment

INDUSTRY

Sponsor class

Stopped Recruitment was early terminated due to slow recruitment. Not linked to any safety concern.

Conditions

Ulcerative Colitis

Interventions

DRUG: SAR339658
OTHER: Placebo

Sponsor

Sanofi